| Pharmaceutical active ingredients: |
| HydrochlorothiazideLisinopril |
| Available forms, composition and doses of Caralpha: |
| N / A |
| Caralpha medical category: |
| Human:Angiotensin-Converting Enzyme inhibitorsThiazide diuretics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C03AX01 - Hydrochlorothiazide, combinationsC09BA03 - Lisinopril and diuretics |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Alpharma |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Acercomp | Hydrochlorothiazide; Lisinopril | AstraZeneca |
| Acercomp Mite | Hydrochlorothiazide; Lisinopril | AstraZeneca |
| Acerdil-D | Hydrochlorothiazide; Lisinopril | Recalcine Laboratorios; Drugtech Laboratorio |
| Apo-Lisinopril / Hctz | Hydrochlorothiazide; Lisinopril | Apotex; Hind Wing |
| Carace Plus | Hydrochlorothiazide; Lisinopril | Bristol-Myers Squibb; United Drug |
| Cipril-H | Hydrochlorothiazide; Lisinopril | Cipla |
| Cipril-H Forte | Hydrochlorothiazide; Lisinopril | Cipla |
| Co-Acetan | Hydrochlorothiazide; Lisinopril | F. Joh. Kwizda |
| Co-Lipril | Hydrochlorothiazide; Lisinopril | Mepha |
| Co-Lipril Mite | Hydrochlorothiazide; Lisinopril | Mepha |